Pressmeddelanden från Inhalation Sciences

Bevaka pressreleaser

Kurs från TradingView

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

Inhalation Sciences

Inhalation Sciences riktade emission är registrerad på Bolagsverket 24 mar 16:30

Inhalation Sciences

Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000 19 mar 13:00

Inhalation Sciences

Kommuniké från extra bolagsstämma i Inhalation Sciences 10 mar 10:10

Inhalation Sciences

Inhalation Sciences optionsinlösen är registrerad hos Bolagsverket och interimsaktier omvandlas till aktier 03 mar 08:00

Inhalation Sciences

KALLELSE TILL EXTRA BOLAGSSTÄMMA I INHALATION SCIENCES SWEDEN AB (PUBL)02 mar 19:10

Inhalation Sciences

Inhalation Sciences tillförs 2,88 MSEK i samband med optionsinlösen och garantiåtagande för teckningsoptioner av serie TO2 27 feb 08:30

Inhalation Sciences

Inhalation Sciences AB (publ) publicerar bokslutskommuniké 2025 18 feb 09:10

Inhalation Sciences

Inhalation Sciences receives new IRS order for DissolvIt® worth approximately EUR 139,000 13 feb 08:30

Inhalation Sciences

Inhalation Sciences meddelar att nyttjandeperioden för teckningsoptioner av serie TO2 inleds idag till fastställd kurs 0,24 kr och att teckningsoptionsinlösen är fullt garanterad 27 jan 12:50

Inhalation Sciences

Inhalation Sciences receives new IRS orders worth EUR 52,000 from global pharmaceutical companies 22 dec 2025 08:30

Inhalation Sciences

Inhalation Sciences receives major IRS order for DissolvIt® from leading global pharma company 11 dec 2025 08:30

Inhalation Sciences

Inhalation Sciences Presented FDA-Funded Study Results on DissolvIt® and the APRINHA Project at the DDL Conference 04 dec 2025 11:20

Inhalation Sciences

Inhalation Sciences receives purchase order worth 160 KEUR from international distributor for the US market 21 nov 2025 08:30

Inhalation Sciences

Inhalation Sciences AB (publ) publicerar delårsrapport för det tredje kvartalet 2025 04 nov 2025 08:30

Inhalation Sciences

Inhalation Sciences hires advisors to evaluate potential acquirers of the company or the company's operations 04 nov 2025 08:30

Inhalation Sciences

Inhalation Sciences anlitar rådgivare för att utvärdera möjliga förvärvare av bolaget eller bolagets verksamhet 24 okt 2025 08:30

Inhalation Sciences

Inhalation Sciences receives IRS order from leading European university hospital 07 okt 2025 09:00

Inhalation Sciences

Inhalation Sciences to Present abstracts from the FDA-Funded Evaluation Study on DissolvIt® and the APRINHA Project at the 2025 DDL Conference 02 okt 2025 08:30

Inhalation Sciences

Inhalation Sciences receives service orders from recurring global pharma customers 19 sep 2025 08:30

Inhalation Sciences

University of Liège highlights the value of PreciseInhale® in advancing Inhalation Research 17 sep 2025 13:45

Inhalation Sciences

Inhalation Sciences launches marketing campaign to increase awareness 01 sep 2025 15:45

Inhalation Sciences

Inhalation Sciences publicerar videointervju med vd och försäljnings- och marknadschef – kommenterar Q2 rapport och aktiviteter framåt 29 aug 2025 08:39

Inhalation Sciences

Komplettering: Inhalation Sciences AB (publ) publicerar delårsrapport för det andra kvartalet 2025 29 aug 2025 08:00

Inhalation Sciences

Inhalation Sciences AB (publ) publicerar delårsrapport för det andra kvartalet 2025 01 jul 2025 10:00

Inhalation Sciences

Inhalation Sciences receives service order from recurring global pharmaceutical customer 24 jun 2025 16:28

Inhalation Sciences

Kommuniké från årsstämma i Inhalation Sciences 23 jun 2025 08:00

Inhalation Sciences

Inhalation Sciences meddelar första dag för handel med teckningsoptioner av serie TO2 och TO3 18 jun 2025 08:00

Inhalation Sciences

Inhalation Sciences meddelar sista dag för handel med BTU 04 jun 2025 17:40

Inhalation Sciences

Inhalation Sciences offentliggör utfall i bolagets företrädesemission 02 jun 2025 08:00

Inhalation Sciences

Inhalation Sciences har genomfört framgångsrikt webbinarium gällande FDA-finansierad DissolvIt[®]-studie 30 maj 2025 08:00

Inhalation Sciences

Ny försäljningschef tecknar i den pågående företrädesemissionen 28 maj 2025 08:00

Inhalation Sciences

Inhalation Sciences meddelar sista dag för handel med uniträtter 27 maj 2025 14:00

Inhalation Sciences

Inhalation Sciences AB (publ) releases Annual Report 2024 27 maj 2025 14:00

Inhalation Sciences

Inhalation Sciences Sweden AB (publ) publicerar årsredovisning för 2024 27 maj 2025 08:00

Inhalation Sciences

Inhalation Sciences utser Ulf Wedenberg till Chief Commercial Officer (CCO)27 maj 2025 08:00

Inhalation Sciences

Inhalation Sciences appoints Ulf Wedenberg as Chief Commercial Officer (CCO)26 maj 2025 13:00

Inhalation Sciences

Föreslagen styrelseledamot tecknar i den pågående företrädesemission 26 maj 2025 08:00

Inhalation Sciences

KALLELSE TILL ÅRSSTÄMMA I INHALATION SCIENCES SWEDEN AB (PUBL)22 maj 2025 17:01

Inhalation Sciences

ISAB webbinarium – genomgång av de positiva resultaten från FDA-studien 22 maj 2025 08:30

Inhalation Sciences

Inhalation Sciences Signs Strategic Agreement with U.S.-based BioLum Sciences, expanding U.S. Presence & Commercial Reach to Advance In Vitro Respiratory Research 22 maj 2025 08:30

Inhalation Sciences

Inhalation Sciences tecknar strategiskt avtal med USA-baserade BioLum Sciences och utökar sin närvaro och kommersiella räckvidd i USA för att främja in vitro-respiratorisk forskning 19 maj 2025 08:00

Inhalation Sciences

Idag inleds teckningsperioden i Inhalation Sciences företrädesemission 16 maj 2025 08:00

Inhalation Sciences

Inhalation Sciences AB (publ) publicerar delårsrapport för det första kvartalet 2025 14 maj 2025 17:40

Inhalation Sciences

Inhalation Sciences offentliggör informationsdokument och teaser i samband med företrädesemission av units 14 maj 2025 08:00

Inhalation Sciences

Inhalation Sciences tidigarelägger delårsrapporten för perioden jan – mar 2025 08 maj 2025 15:05

Inhalation Sciences

Kommuniké från extra bolagsstämma i Inhalation Sciences Sweden AB (publ)08 maj 2025 08:30

Inhalation Sciences

Inhalation Sciences får nya IRS ordrar från återkommande kunder – ökad efterfrågan i linje med regulatoriska krav 08 maj 2025 08:30

Inhalation Sciences

Inhalation Sciences receives new IRS orders from returning customers – increased demand in line with regulatory requirements 29 apr 2025 08:30

Inhalation Sciences

Inbjudan till investerarpresentation för genomgång av de positiva resultaten från FDA-studien 24 apr 2025 08:00

Inhalation Sciences

Inhalation Sciences AB reports positive primary and secondary study results in the FDA-funded study of DissolvIt® and receives approval from the FDA to publish the study results 24 apr 2025 08:00

Inhalation Sciences

Inhalation Sciences AB rapporterar positiva primära och sekundära studieresultat i den FDA-finansierade studien av DissolvIt® och erhåller godkännande från FDA om publicering av studieresultaten 15 apr 2025 08:35

Inhalation Sciences

Inhalation Sciences receives new order worth 41,000 Euro from returning big pharma customer 15 apr 2025 08:35

Inhalation Sciences

Inhalation Sciences får ny order värd 41.000 euro från en återkommande big pharma kund 08 apr 2025 11:00

Inhalation Sciences

KALLELSE TILL EXTRA BOLAGSSTÄMMA I INHALATION SCIENCES SWEDEN AB (PUBL)07 apr 2025 17:50

Inhalation Sciences

Inhalation Sciences avser att genomföra en företrädesemission av units om cirka 15,2 MSEK 03 mar 2025 10:35

Inhalation Sciences

Inhalation Sciences well-positioned as FDA emphasizes dissolution testing for inhalation studies 28 feb 2025 08:30

Inhalation Sciences

Inhalation Sciences AB (publ) publicerar bokslutskommuniké 2024 28 feb 2025 08:30

Inhalation Sciences

Inhalation Sciences AB (publ) releases Q4 / Year-End Report 2024 13 jan 2025 08:30

Inhalation Sciences

Inhalation Sciences’ launch of the XposeALI[®] in vitro module with microperfusion 10 jan 2025 08:30

Inhalation Sciences

Inhalation Sciences receives IRS order worth SEK 212,000 from global leader in generics and biosimilars 09 jan 2025 08:30

Inhalation Sciences

Inhalation Sciences submits Project Report and Summary Data to the FDA for Final Review 17 dec 2024 11:40

Inhalation Sciences

Inhalation Sciences receives new orders totalling 33,900 Euro for technical service contracts 20 nov 2024 08:30

Inhalation Sciences

Inhalation Sciences AB (publ) releases Q3 Report 2024 20 nov 2024 08:30

Inhalation Sciences

Inhalation Sciences AB (publ) publicerar delårsrapport för tredje kvartalet 2024 16 okt 2024 08:30

Inhalation Sciences

Inhalation Sciences provides latest status update on ongoing FDA BAA dissolution research project 10 okt 2024 08:30

Inhalation Sciences

Publication of positive performance of ISAB’s in vitro module demonstrated in collaboration with Karolinska Institutet 04 sep 2024 15:00

Inhalation Sciences

Kommuniké från extra bolagsstämma i Inhalation Sciences Sweden AB (publ)28 aug 2024 08:30

Inhalation Sciences

Inhalation Sciences AB (publ) releases Q2 Report 2024 28 aug 2024 08:30

Inhalation Sciences

Inhalation Sciences AB (publ) publicerar delårsrapport för andra kvartalet 2024 16 aug 2024 08:30

Inhalation Sciences

KALLELSE TILL EXTRA BOLAGSTÄMMA i INHALATION SCIENCES SWEDEN AB (PUBL)15 aug 2024 08:30

Inhalation Sciences

Surge of new orders totalling 50,000 Euro signals new sales season for Inhalation Research Services 12 aug 2024 12:56

Inhalation Sciences

Forthcoming changes in Inhalation Sciences’ Board of Directors 13 jun 2024 10:35

Inhalation Sciences

Inhalation Sciences receives new IRS order for DissolvIt® study worth 57,000 Euro from leading inhalation big pharma 29 maj 2024 11:52

Inhalation Sciences

Watch ISAB CEO go behind the headlines in high-value Q1 interview 28 maj 2024 08:00

Inhalation Sciences

Inhalation Sciences AB (publ) releases Q1 Report 2024 28 maj 2024 08:00

Inhalation Sciences

Inhalation Sciences AB (publ) publicerar delårsrapport för första kvartalet 2024 22 maj 2024 11:08

Inhalation Sciences

Inhalation Sciences presents at well-received FDA public workshop GDUFA 21 maj 2024 10:00

Inhalation Sciences

Inhalation Sciences receives new order worth 60,000 Euro from long-term big pharma client 14 maj 2024 13:45

Inhalation Sciences

Kommuniké från årsstämma i Inhalation Sciences Sweden AB (publ)11 apr 2024 08:30

Inhalation Sciences

Inhalation Sciences AB (publ) releases Annual Report 2023 11 apr 2024 08:30

Inhalation Sciences

Inhalation Sciences Sweden AB (publ) publicerar årsredovisning för 2023 10 apr 2024 08:30

Inhalation Sciences

Inhalation Sciences to present at FDA’s public workshop GDUFA on May 20th, 2024 09 apr 2024 08:00

Inhalation Sciences

KALLELSE TILL ÅRSSTÄMMA i INHALATION SCIENCES SWEDEN AB (publ)05 apr 2024 13:00

Inhalation Sciences

Komplettering till ISAB:s bokslutskommuniké 2023 11 mar 2024 08:30

Inhalation Sciences

Positive results of first-in-human clinical trial of PreciseInhale now published in European Journal of Pharmaceutical Sciences 28 feb 2024 08:30

Inhalation Sciences

Inhalation Sciences AB (publ) releases Q4 / YE Report 28 feb 2024 08:30

Inhalation Sciences

Inhalation Sciences AB (publ) publicerar bokslutskommuniké 2023 22 jan 2024 08:30

Inhalation Sciences

Inhalation Sciences signs new partnership with Actarmo Medical: End-to-end offering for respiratory drug development Services 29 dec 2023 08:30

Inhalation Sciences

Inhalation Sciences secures product service contract worth 47,000 Euro 13 dec 2023 10:37

Inhalation Sciences

Inhalation Sciences’ captures interest and interaction at its latest industry webinar ‘Inhaled Biologics’22 nov 2023 08:30

Inhalation Sciences

Inhalation Sciences AB (publ) publicerar delårsrapport för tredje kvartalet 2023 22 nov 2023 08:30

Inhalation Sciences

Inhalation Sciences AB (publ) releases Q3 Report 2023 21 nov 2023 08:30

Inhalation Sciences

Inhalation Sciences wins new IRS order worth 100,000 Euro (1.14 MSEK) from prominent European pharma company 13 nov 2023 08:30

Inhalation Sciences

Inhalation Sciences wins new purchase order worth 276,450 Euro (3.2 MSEK)08 nov 2023 08:30

Inhalation Sciences

Inhalation Sciences secures new order worth 54,700 Euro 31 okt 2023 14:16

Inhalation Sciences

Inhalation Sciences’ CEO at Redeye Life Science Day 2023 18 okt 2023 08:30

Inhalation Sciences

Inhalation Sciences strengthens its US IP position with new patent approval 16 okt 2023 08:30

Inhalation Sciences

Inhalation Sciences secures 188,900 Euro order from top-five global generics manufacturer 29 sep 2023 08:52

Inhalation Sciences

Inhalation Sciences signs collaboration agreement with leading Indian multinational pharma company 29 aug 2023 08:30

Inhalation Sciences

Inhalation Sciences AB (publ) releases Q2 Report 2023